To determine whether unobtrusive long-term in-home assessment of walking speed and its variability can distinguish those with mild cognitive impairment (MCI) from those with intact cognition.
It is of substantial importance to detect dementia at its earliest phases to sustain independence, to optimize treatment, to understand preclinical biology, and to ultimately develop prevention strategies. Past studies have found that slower walking speed and poorer motor function are associated with mild cognitive impairment (MCI) and are predictors of progression to frank dementia. [1] [2] [3] [4] However, it is difficult to identify changes in these functions because changes evolve slowly over time and change measures have high test-to-test variability. Further, current methods for assessing this change rely largely on sparsely spaced or annual assessments that provide too few data points to discern subtle changes. An alternative to this approach is to deploy unobtrusive passive monitoring systems in people's homes, providing continuous assessment of daily activity and behaviors of interest. This kind of pervasive computing model has been established by the Intelligent Systems for Assessing Aging Change (ISAAC) study, 5, 6 to identify early signs of cognitive decline. We have previously shown that in-home walking speed and its short-term variability could distinguish those with MCI from those with intact cognition cross-sectionally 7 in a few volunteers. In the current study, we examined whether longitudinal trajectories of walking speed and speed variability could differentiate participants with MCI defined at baseline from those who are cognitively intact throughout their follow-up, using data collected over 3 years in the homes of 85 independently living older participants. We hypothesized that participants with MCI would experience declining walking speed as well as changes in walking speed variability. METHODS Participants. Participants were recruited from the Portland, Oregon, metropolitan area through advertisement and presentations at local retirement communities as part of the ISAAC longitudinal cohort study. Details of the study protocol are published elsewhere. 5, 6 In brief, entry criteria for the study included 1) age 70 or older, 2) independent living in a larger than one-room apartment, 3) Mini-Mental State Examination (MMSE) score Ͼ24 and Clinical Dementia Rating scale 8 score Յ0.5, and 4) average health for age: Medical illnesses that would limit physical participation (e.g., wheelchair bound) or likely lead to untimely death (e.g., certain cancers) were exclusions. Enrollment began in March 2007 and continued on a rolling basis until September 2009 with a total of 265 participants. The participants lived in a variety of settings from apartments in organized retirement communities to free-standing single-family homes. For this analysis, of 108 participants living alone (the sample recruited for walking speed analyses), we excluded 14 individuals with incident MCI detected during the follow-up and one subject missing the Tinetti balance score, leaving 93 participants.
Standard protocol approvals, registrations, and patient consents. Protocol and consent forms were approved by the Oregon Health & Science University Institutional Review Board. All participants provided written informed consent.
Clinical assessment procedures. Participants were clinically assessed at baseline and during annual visits in their home using a standardized battery of tests consisting of physical and neurologic examinations. 5 Participants were administered the MMSE, Geriatric Depression Scale, 9 Functional Activities Questionnaire (FAQ), 10 and motor portion of the Unified Parkinson's Disease Rating Scale (UPDRS). 11 Balance was assessed by the Tinetti Performance-Oriented Assessment of Mobility (Tinneti balance). 12 There have been many different scoring systems reported for this scale. 13 By convention at our center, balance is measured on a scale of 0 -26 with higher scores indicating better performance. Health status was assessed by the modified Cumulative Illness Rating Scale (CIRS). 14 Cognitive status. Diagnosis of MCI was made using the Petersen criteria 15 operationalized as absence of dementia, intact functional activities (being able to conduct FAQ activities without any help in all but 2 or fewer FAQ items 10 ), normal general cognitive function (MMSE score Ͼ24), and objective impairment on one or more of 6 neuropsychological tests considered to be representative of 5 cognitive domains: 1) memory, Logical Memory Delayed Recall 16 ; 2) executive function, Category Fluency Animals 17 or Trail Making B 18 ; 3) attention, Wechsler Adult Intelligence Scale (WAIS) Digit Symbol 19 ; 4) language, Boston Naming Test 20 ; and 5) visuospatial function, WAIS-Revised Block Design. 21 Amnestic MCI (aMCI) was defined as impairment in the memory domain with or without impairment in other domains. Nonamnestic MCI (naMCI) was defined as impairment in one or more nonmemory domains and no memory impairment. Impairment on neuropsychological testing was defined as a score of 1.5 SD or more below the predicted mean value for subject-specific age, sex, and educational levels, based on normative values generated in the past. 22 Walking speed assessment. Continuous activity data were collected using an unobtrusive activity assessment system by installing several types of motion and contact sensors in the home of each participant. Metrics assessed by the sensors include walking speed, total daily activity, and time out of home. The assessment of walking speed and its data validation process are described in detail elsewhere. 6, 23 In brief, motion sensors with a restricted field of view were installed along a hallway so they would detect only when a person passed directly under them. Data from all sensors were wirelessly received by a dedicated research computer placed in the subject's home and then were time-stamped and stored in a structured query language database. All data were automatically uploaded daily to a central database in the project data center. Walking events Ͻ20 or Ͼ160 cm/second were excluded as outliers (values greater than 2 SD from the mean of all walks). Participants reported via computer when overnight visitors were present. Days with overnight guests and days when staff visited the home were excluded as a part of our quality control protocol. Weekly walking speed was calculated by taking the median of all available walking speeds each day (meters per second) and then was averaged for each week (weekly mean) (figure e-1 on the Neurology ® Web site at www.neurology.org). To assess the relative magnitude of walking speed variability, we calculated the weekly coefficient of variation (COV) of walking speed by using the weekly mean and its SD during each week (i.e., COV ϭ [SD/weekly mean] ϫ 100, unit free). Weekly walking speed and COV were log (base e)transformed to address the skewed distributions in the analysis.
Data analysis. Characteristics at baseline were compared between the cognitively intact participants and participants with MCI using the Student t test or the Wilcoxon rank sum test for continuous variables and the Pearson 2 test and Fisher exact test for categorical variables. We examined whether there are distinct trajectory patterns of walking speed and its variability over time. SAS procedure PROC TRAJ 24 was used for this data discovery process. This procedure combines 2 separate statistical models and estimates their parameters simultaneously using maximum likelihood estimates. The first model builds trajectories for the different latent groups as a function of time from baseline. Quadratic or cubic function of time are included if it improves the model fitness indicated by the Bayesian information criterion (BIC). The second builds a multinomial regression model that examines the associations of covariates (here baseline characteristics of the subject) with the probability of membership in the homogeneous latent groups. Examples of the application of this method to clinical outcomes were described previously. 25, 26 Covariates included in the trajectory models were age at baseline, sex, years of education, cognitive status, and Tinneti balance score. Other potential confounders (UPDRS, CIRS, body mass index, FAQ, and height) were not included in the final models because there were no differences in these values between the intact and MCI groups at baseline (described later). The BIC was used to identify the optimal number of homogeneous groups. Analyses were performed using SAS 9.2 (SAS Institute, Cary, NC).
RESULTS
Among 93 participants, the distribution of cognitively intact participants and participants with aMCI and naMCI was 54, 8, and 31, respectively. Their characteristics are given in table 1. Participants with aMCI and naMCI differed in in-home walking speed during the baseline week, suggesting that trajectories in walking speed between these 2 types of MCI are potentially different. Therefore, we did not combine the 2 types of MCI in the statistical analysis, but focused on naMCI, as this latter group had sufficient sample size. Participants with naMCI had lower (worse) Tinetti balance scores and slower mean in-home walking speeds during the baseline week compared with cognitively intact participants. As expected, all neuropsychological test scores were different between the cognitively intact participants and the participants with naMCI. CIRS, body mass index, UPDRS, FAQ scores, and height were not different between the 2 groups. By the third annual assessment, 2 participants were lost to follow-up and 4 participants were deceased (7.0%). These participants were included in the analyses using the available information until their drop out in the framework of mixed-effects latent trajectory models.
Trajectory analyses of walking speed. Trajectory analyses identified 3 distinct groups of walking speed trajectories as the best model based on the BIC ( figure  1A) . The procedure calculates the probability of each participant belonging to each trajectory and identifies a participant as belonging to one trajectory based on the highest probability. Figure 1A shows the estimated trajectories, using the model-assigned group identification for each participant. Based on the shapes of walking speed trajectories, we named them fast, moderate, and slow walkers, respectively (trajectory lines from top to bottom in figure 1A ). The figure shows that speed is relatively stable with a slight decline (i.e., getting slower) over time for the first 2 groups, but the slow walker group showed a steeper declining trend. Walking speed trajectories as depicted in figure  1A showed linear trajectories without any overlap. Therefore, as a post hoc analysis, we used mixedeffects models (random intercept) with an indicator variable of cognitive status (naMCI vs cognitively intact) and its interaction with time to estimate the average difference in the amount of decline between the 2 groups. The results are shown in table 3. Participants with naMCI showed additional decline in walking speed (m/second) by 0.0006 point ( p Ͻ 0.0001) per week, meaning approximately 10% shorter m/second in 181 weeks (approximately 3.5 years) (e (Ϫ0.0006ϫ181) ϭ 0.90). For example, a baseline speed of 0.6 m/second means it takes 50 seconds to walk 30 m (30/0.6 ϭ 50). Given that a cognitively intact participant would remain at this walking speed, the counterpart with MCI would take about 56 seconds to walk 30 m (30/0.54 ϭ 55.6), i.e., requiring about 6 seconds longer to walk the same 30-m distance. Controlling for race and height did not change the result.
Trajectory analysis of COV of walking speed. The trajectory analysis identified 4 distinct trajectory groups of walking variability (COV) as the best model based on the BIC. Figure 1B shows the estimated trajectories. Group 1 can be characterized as having the highest COV at baseline followed by a further increase in COV and then sharply declining COV. Groups 2 and 3 were in the middle in COV at baseline, and their COV remained relatively stable with only a slight increase over time. Finally, group 4 started off with the lowest COV and experienced de- Table 2 Results of multinomial logit model showing the association between walking speed trajectories and baseline characteristics creasing COV over time. The results of the association between baseline characteristics and the 4 trajectories based on multinomial logit models estimated jointly with the trajectory model are found in table e-1. The results showed that participants with naMCI were less likely to be in the groups with stable COV but were more likely to be in either the group with the highest (group 1) or the lowest COV at baseline (group 4). By using the predicted group assignment for each subject, the proportion of naMCI among each trajectory were found to be 53.3%, 33.3%, 16.7%, and 61.5% for groups 1, 2, 3, and 4, respectively (Pearson 2 test, p ϭ 0.02). DISCUSSION We describe for the first time trajectories of home-based daily walking speeds and their variability that are associated with naMCI over 3 years. Participants with naMCI were characterized by a slowing of walking speed. Furthermore, 2 distinct trajectories of COV (the highest and lowest variability) were found to be predominantly associated with naMCI.
Walking speed and other motor activities have previously been identified as differentiating those with MCI syndromes and cognitive decline or as predictors of progression to frank dementia. [1] [2] [3] [4] At least 1 study has suggested that gait changes predicting MCI may begin even decades before cognitive decline is clear. 4 The longitudinal detection of these subtle changes that are not overtly disabling is challenging. Capturing multiple episodes of walking during the day can provide the opportunity to examine intraindividual variability in this measure, which may be sensitive to cognitive changes beyond absolute speed. Our results show that this appears to be the case.
Natural history of walking speed and its variability among participants with naMCI. Participants with naMCI were predominantly found in 2 trajectory groups of walking speed variability: one characterized as having the highest COV at baseline followed by a further increase in COV and then sharply declining COV and another beginning with the lowest COV and experiencing decreasing COV over time. A higher proportion of participants with naMCI in the trajectory groups representing the opposite ends of the spectrum of change might suggest the general trajectories of clinical outcomes associated with various diseases. That is, biologic systems typically do not fail outfight, but initially demonstrate a period of increased variability as physiologic or functional reserve diminishes. 27 Figure 2 illustrates the hypothetical model depicting this phenomenon: at the early stage of disease, subjects may begin to develop increasing variability in clinical outcomes such as dayby-day fluctuations in walking speed, balance, functional abilities, mood, or cognitive performance. This phase of increasing variability would be the result of physiologic or functional reserve trying to compensate for the dysfunction associated with the disease. However, once compensatory systems fail or pathologic burdens go beyond the level sustainable by reserve, the variability or short-term fluctuation diminishes because biologic systems lose their ability to preserve premorbid function. Given this theoretical model, group 1 depicted in figure 1B would be transiting the early disease stage (early MCI: high baseline variability with further increasing variability, followed by a decreasing variability), whereas group 4 would represent the later stage (late MCI: lowest baseline and declining variability). To shed light on this hypothesis, we examined whether the participants with naMCI in group 1 had better scores on cognitive tests (i.e., early MCI) than the participants with naMCI in group 4 (late MCI). We found that among all test scores, the participants with naMCI in group 1 scored better than those in group 4, although no scores were statistically significant, possibly due to small sample sizes (results shown in table e-2). The ability to assess the trajectory of change through the course of MCI requires longitudinal data and the ability to measure variability with sampling durations frequent enough to capture fluctuations. The home-based system we used afforded the opportunity to examine the trajectory of walking speed as well as the trajectory of its variability.
Figure 2 Hypothetical trajectory of variability associated with disease progression
Clinical markers may include walking speed, functional abilities, mood change, cognitive function, and others. The figure shows that biologic systems typically do not fail outfight but initially demonstrate a period of increased variability as physiologic or functional reserve diminishes. We hypothesize that this large fluctuation or variability typically happens during the early mild cognitive impairment (MCI) stage. Monitoring in-home activities unobtrusively and creating data with time intervals frequent enough to capture intraindividual variability such as day-by-day, week-by-week, or month-by-month fluctuations may assess this hypothesis and lead to early identification of future cognitive decline.
